Wednesday, July 11, 2012

Human Body Scan Software


The digitization of images in the medical area is now a must. Almost all specialties: traumatology, cardiology, ophthalmology, internal medicine, urology., Require imaging pictures, films, videos, echocardiograms, MRIs, CT scans, and even diagnostic imaging, tests, stories, photos patients and their injuries, etc.., everything can be digitized and taken to an image server, which will be updated and accessed by a powerful CRM software for managing medical images and their corresponding hardware.

If there is a promotional medium used by all pharmaceutical companies, without exception, and probably universally, that is the pen. I know of no medical visits delegate whose car trunk box does not contain any of these objects repelta so common in our daily lives with the corresponding mark stamped on them. In Spain, its use in drug promotion is permitted provided that the cost does not exceed € 30, as determined by the current code Farmaindustria.

The novelty is that in the U.S., as published in The New York Times recently, from January 1 this year, the PhRMA (The Pharmaceutical Research and Manufacturers of America) opens unnuevo code that, among other things, prohibits the delivery of any object brand-reminder to health professionals. From now on Americans will buy their pens at the kiosk and certainly more of a promotional gift company will close its doors permanently. In addition, poor Dr. Caren, a cardiologist at Los ANGELES, no longer able to expand its impressive private collection of over 1,200 pens, has been recibidiendo the hands of the medical visit delegates over his last years in active. Nor make it easy to Nathan Anderson, a resident in internal medicine since 2006 has an interesting blog (Drug Rep Toys) dedicated solely to show the amazing gadgetry that receives daily from the pharmaceutical industry to remember their brands in the time of prescription.

I know, so far no serious study that has analyzed the actual effectiveness and ROI of these reminders of brand, but I would doubt the same for several reasons: A general practitioner receives at least two or three branded gimmicks a week. Most end up in the trash or in the hands of the son of the doctor within 24 hours of delivery. Most of them break down the four or five applications due to its very poor quality, resulting in "disappointment" by the receiver of the gift. Those who survive share doctor's office temporarily with many other similar objects of so many brands, often competing with each other. Those who have the honor of spending a few days in the pocket of the doctor, do not fulfill the function for which they have been committed, because in that place are out of sight of the prescriber.

I do not know how these elements have been able to help increase the spontaneous awareness of brands that use them in promotional history, but I am sure of one thing: no help at all to what should be the first communication objectives of those marks, credibility and differentiation. It is difficult to calculate how much the Spanish pharmaceutical industry invests in this type of media. But I will venture to make an estimate on Ulimo 5 years have sold over 500 branded drugs in Spain, assuming that 50% use a pen as an advertising medium and distributed 15,000 units on average per year, the annual investment may be around 2 million euros, only pens.

Is not it about time that pharmaceutical companies of our country raise the profitability of such investments "historic" and bet on more innovative ways to make your mark is at the top of mind of the prescriber?

No comments:

Post a Comment